EGFR and lung cancer: Epidermal growth factor receptor (EGFR) signalling in lung cancer activates the PD1 immune checkpoint to promote immune evasion12 and an EGFR-neutralizing antibody stimulates immunogenic cell death in colorectal cancers13.